Well it all depends on what naysayers say, as to whether they are right or wrong. If they are talking the SP then they are right. If they are talking about the tech, and it not being good then they are wrong. There are too many companies that have come out and either used or partnered with Brainchip for the tech not to be good. Is it good enougn to be a commercial product? yes.
Why, several companies are already on board. Universities have decided to set up courses to teach the tech. Mercedes have used it in their SCIENCE FICTION cars, and many, many companies have decided to combine the tech in with their own.
Now we come to the nay sayers favorite topic. WHAT ABOUT REVENUE?
This is where they are correct. But why?
The only people that can answer this are inside the company and insiders of the companies they are trying to sell to. Is it not needed, yet? Is it too far ahead still? Have companies already spent too much on their own R&D? Are they waiting for something else? Who the hell knows, but one thing that is 100%, you and the other clowns (mostly 1,2 and 3) don't have a friggin clue.
- Forums
- ASX - By Stock
- BRN
- 2024 BrainChip Discussion
2024 BrainChip Discussion, page-667
-
- There are more pages in this discussion • 6,295 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $361.9M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $878.2K | 4.371M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 1444914 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 388739 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
62 | 1344164 | 0.195 |
62 | 1739410 | 0.190 |
33 | 1759832 | 0.185 |
50 | 1530443 | 0.180 |
16 | 598862 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 337097 | 7 |
0.205 | 914687 | 15 |
0.210 | 1398298 | 25 |
0.215 | 506951 | 23 |
0.220 | 758461 | 24 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online